News

BMA appeals GMC fee rise

29-Aug-08

The BMA is appealing to the High Court to stop GPs over the age of 65 being charged to remain on the GMC's register.

The GMC plans to abolish the exemption from the Annual Retention Fee (ARF) for doctors aged over 65. This would mean paying a fee of £390.

The BMA is currently applying for a judicial review in October to prevent the changes from going ahead. It is advising GPs over 65 to wait until after the review to decide whether to pay the fee.

A BMA spokesman said: ‘The BMA regrets that we have been forced to pursue this course of action, but we feel it is necessary to do so on behalf of the thousands of retired doctors who have given many years of service to the NHS.’

tom.ireland@haymarket.com

Comment below and tell us what you think

Comments

syed zaki-ahmad

29/08/2008

Thanks for BMA to take this issue for judicial review.

It is unfortunate that facilities are provided for senior citizen in this country but GMC thinks otreway round.

DR. ZAKI SOLIHULL

vinod k seth

31/08/2008

The GMC considers exemption of ARF as age discrimnation.Could the Governmment be considered guilty of age discrimnation as it provides certain facilities and benefits to Senior Citizens ,I wonder.

Dr.V.K.Seth Sully

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Jobs

 

Job of the Week

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more